Condition
Facial Nerve Paresis
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03508440Phase 2Completed
Intratympanic Steroid for Bell's Palsy
NCT04457492Not ApplicableTerminatedPrimary
Functional Electrical Stimulation for Facial Muscles
NCT03822728Not ApplicableCompleted
Intra-parotid Facial Nerve Imaging in Parotidectomy
NCT05568108UnknownPrimary
Using the Masseteric Nerve for Facial Nerve Reanimation
Showing all 4 trials